每年研究成果
研究成果
2016
Polymeric nanoparticles and cancer: Lessons learnt from CRLX101
Gritli, I., Garmey, E., Eliasof, S., Tellez, A., Davis, M. E. & Yun, Y., 2016, Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation. 51 編輯 Royal Society of Chemistry, 卷 2016-January. p. 199-232 34 p. (RSC Drug Discovery Series; 卷 2016-January, 編號 51).研究成果: 書貢獻/報告類型 › 章節
1
引文
斯高帕斯（Scopus）
2009
Alternative splicing as a therapeutic target for human diseases
Dery, K. J., Gusti, V., Gaur, S., Shively, J. E., Yen, Y. & Gaur, R. K., 十二月 1 2009, Therapeutic Applications of RNAi: Methods and Protocols. Reidhaar-Olson, J. & Rondinone, C. (編輯). p. 127-144 18 p. (Methods in Molecular Biology; 卷 555).研究成果: 書貢獻/報告類型 › 章節
7
引文
斯高帕斯（Scopus）
2008
Redox property of ribonucleotide reductase small subunit M2 and p53R2
Liu, X., Xue, L. & Yen, Y., 十二月 1 2008, Advanced Protocols in Oxidative Stress I. Armstrong, D., Armstrong, D. & Armstrong, D. (編輯). p. 195-206 12 p. (Methods in Molecular Biology; 卷 477).研究成果: 書貢獻/報告類型 › 章節
15
引文
斯高帕斯（Scopus）
2005
8 Growth arrest DMA damage-inducible gene 45 β in human hepatocellular carcinoma
Yen, Y., 十二月 1 2005, Molecular Genetics, Liver Carcinoma, and Pancreatic Carcinoma. Hayat, M. A. (編輯). p. 207-215 9 p. (Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas; 卷 3).研究成果: 書貢獻/報告類型 › 章節